Ronald Bartel

3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors.

Chequers Partenaires SA engages in the provision of private equity funds investment management services. It offers LBO/MBO, sector consolidation, growth equity, shareholders restructuring, carve-out, and recovery situations. The company was founded in 1972 and is headquartered in Paris, France.

Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.

Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.

Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.

VM Capital Advisors GmbH (Vorndran Mannheims) is the private equity subsidiary of VM Principals GmbH, itself a subsidiary of VM Holding GmbH & Co. KG in Germany, headquartered in Dusseldorf, Germany. Formerly known as Ventizz Capital Partners Advisory AG, the firm was founded in 2000 by Dr. Helmut Vorndran, Reinhard Löchner and NPM Capital NV and was renamed in 2012 to reflect a focus on private equity and buyouts. They focus on technology-oriented growth companies, utilizing the entrepreneurial background and the international operating experience of their management team to differentiate themselves from other private equity firms. Located in Düsseldorf with an advisory office in St. Gallen, Switzerland, Vorndran Mannheims advises Delaware and Jersey-based funds which invest in buyouts and growth equity for small and medium-sized high-tech companies primarily in German-speaking Europe. Their funds are backed by fund-of-funds, university endowments and foundations, pension funds, industrial companies and banks and insurance companies.

DPE Deutsche Private Equity GmbH (DPE) is an independent private equity firm founded in 2007 by Volker Hichert and Marc Thiery. The firm is headquartered in Munich, Germany.

Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.

Ambienta SGR SpA (Ambienta) is a private equity firm founded in 2007 by Giuseppe Tronchetti Provera, Rolando Polli and Nino Tronchetti Provera. The firm is headquartered in Milan, Italy with additional offices in Munich, London and Paris.

Founded in 2014, Emeram Urbanics Holding Ltd. is a holding British company that operates subsidiaries in the wholesale and retail apparel industry. The company is based in Manchester, UK.

Founded in 2014, Emeram Urbanics Ltd. is a British company that manufactures and distributes apparel and accessories. Part of EMERAM Capital Partners GmbH, the company is based in Manchester, UK.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

LeadX Capital Partners (LeadX) is a venture capital and growth investment division of Hospitality Digital GmbH, ultimately owned by Metro AG. The firm was founded in 2016 and is headquartered in Munich, Germany, with additional offices in Dusseldorf, Germany and Paris, France.

thinkstep AG operates as a holding company, which provides compliance solutions, as well as compliance software, data, and consulting in the fields of sustainably management. It distributes its products under the GaBi Software, SoFi Software, LCA Data, and SoFi Content brands. The company was founded by Michael Betz and Robert Gabriel in 1991 and is headquartered in Leinfelden-Echterdingen, Germany.

Hospitality Digital GmbH engages in the provision of digital solutions for the hotel, restaurant, and retail trade industries. It offers an online platform for the creation of websites, management and organization of table reservations, web listing, and collection of guest data, as well as tools for the calculation of cost of sales and optimal sales price. The company is headquartered in Düsseldorf, Germany.

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US.

Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.